Epitopea Ltd has made four appointments to its scientific advisory board, bringing the SAB to six members along with company co-founder Pierre Thibault and chair Michael Kalos. The new members are: Nahum Sonenberg, a professor at McGill University, Canada and an expert in translational control; Nina Bhardwaj, a professor of medicine and urology at the Icahn School of Medicine, Mount Sinai, US, and an expert in human dendritic cell biology; Margaret Callahan, a professor of medicine and immunology at a UConn Health cancer centre with expertise in immuno-oncology, clinical trial design and translational research; and, Craig L. Slingluff, a professor of surgery at the University of Virginia, US and an expert in melanoma immunology and cancer vaccine development.
The appointments come as the UK/Canadian company advances its RNA-based cancer immunotherapies, focusing on tumour-specific antigens known as Cryptigen TSAs, towards the clinic.
Epitopea announced the appointments on 18 September 2025.
Copyright 2025 Evernow Publishing Ltd.